COMMUNIQUÉS West-GlobeNewswire

-
NANOBIOTIX provides update on the global development of its lead product NBTXR3
09/11/2017 -
Skyline Medical Inc. Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand
09/11/2017 -
United Health Products Inc. Announces Hemostyp® as featured product of Dick’s Sporting Goods Advanced Wound Care Kit
09/11/2017 -
Herantis Pharma Plc's directed share issue
09/11/2017 -
Press Release PetVivo Adds Mr. David Merrill to the Board of Directors
09/11/2017 -
SoldierStrong Announces 2017 SoldierScholar Recipients
09/11/2017 -
LifeLabs Announces Partnership with the Pediatric Oncology Group of Ontario in support of childhood cancer
09/11/2017 -
Extreme Definition. Exceptional Clarity. Extraordinary REALISM. by Konica Minolta Healthcare, at RSNA
09/11/2017 -
Nextech Presents 4x Faster EMR at the American Academy of Ophthalmology Annual Meeting
09/11/2017 -
TOMI Environmental Solutions, Inc. Awarded Group Purchasing Agreement With Premier
09/11/2017 -
Rexahn Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
09/11/2017 -
Immuron Successfully Completes NASH Phase II Clinical Study Milestone
09/11/2017 -
ADMA Biologics Announces Pricing of Follow-On Offering
09/11/2017 -
Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA
09/11/2017 -
Devonian Announces Initiation of Phase IIa Clinical Trial of Thykamine™ in Adult patients with Mild-to-Moderate Atopic Dermatitis
09/11/2017 -
Devonian annonce l’initiation de l’étude clinique de Phase IIa du Thykamine(MC) chez les patients atteints de Dermatite Atopique légère à modérée
09/11/2017 -
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights
09/11/2017 -
UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017 -
Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase 3 RESULT Clinical Study of Sollpura
09/11/2017
Pages